Everus Construction Group, Inc. vs LENNAR CORP /NEW/, two Homebuilders stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where ECG and LEN diverge most: on revenue growth, ECG reads +30.5% and LEN reads -8.3%; on debt / equity, ECG reads 0.36 and LEN reads 0.00. The rest of the comparable metrics sit closer together. What LEN's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | ECG | LEN |
|---|---|---|
| Price | $122.62 | $76.67 |
| Market cap | $6.3B | $18.2B |
| Sector | Homebuilders | Homebuilders |
| Stage | Growth | Mature |
| P/E | 24.6 | 14.5 |
| P/B | 8.12 | 0.84 |
| P/S | 1.47 | 0.57 |
| EV/EBITDA | 17.9 | 119.8 |
| Revenue growth | +30.5% | -8.3% |
| Gross margin | 14.8% | — |
| Operating margin | 9.1% | — |
| Net margin | 6.0% | 4.1% |
| Return on equity | 32.9% | 6.0% |
| Return on assets | 12.4% | 3.9% |
| Return on invested capital | 26.1% | 0.4% |
| FCF yield | 4.0% | 4.4% |
| Debt / equity | 0.36 | 0.00 |
| Current ratio | 1.59 | — |
| Altman Z (solvency) | 5.93 | 7.92 |
| Piotroski F (quality) | 6 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.